PAVM
PAVM
NASDAQ · Health Care

Pavmed Inc

$4.82
+0.07 (+1.47%)
Financial Highlights (FY 2026)
Revenue
761.2K
Net Income
4.30M
Gross Margin
-207.0%
Profit Margin
564.8%
Rev Growth
-42.8%
D/E Ratio
0.33
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -207.0% -207.0% 44.0% 44.0%
Operating Margin -30,794.4% -27,714.9% 8.6% 7.3%
Profit Margin 564.8% 536.6% 6.6% 6.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 761.2K 1.33M 6.38M 6.70M
Gross Profit -1,575,897 -2,756,510 2.81M 2.95M
Operating Income -234,393,194 -368,994,008 548.6K 488.5K
Net Income 4.30M 6.77M 418.8K 465.2K
Gross Margin -207.0% -207.0% 44.0% 44.0%
Operating Margin -30,794.4% -27,714.9% 8.6% 7.3%
Profit Margin 564.8% 536.6% 6.6% 6.9%
Rev Growth -42.8% -42.8% +12.0% -1.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 4.45M 4.45M 2.13M 1.84M
Total Equity 13.62M 13.62M 6.09M 6.42M
D/E Ratio 0.33 0.33 0.35 0.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -233,258,793 -387,608,629 672.1K 715.5K
Free Cash Flow 349.1K 300.8K